TARGETING NSP1 PROTEIN COULD BE A PATHWAY FOR COVID-19 THERAPY
(AGENPARL) – DALLAS (TEXAS), mar 16 febbraio 2021 The virus SARS-CoV-2 targets the RNA export pathway to block host RNA in the nucleus and promote infection. Illustration by Angela Diehl DALLAS – Feb. 16, 2021 – A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes......